A Study of LY3493269 in Participants With Type 2 Diabetes

NCT04515576 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY3493269
DRUG: Dulaglutide
DRUG: Placebo

Sponsor

Eli Lilly and Company